{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-23-000341","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2023-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.233396+00:00","generated_at":"2026-06-18T03:07:06.597724+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lifeloc Tech reports 2022 net loss of $456K despite 20% revenue growth to $8.482M","bullets":["Revenue $8.482M (+20% YoY); net loss $456K (($0.19)/share) vs net profit $676K ($0.27/share) in 2021.","One-time gain of $108K from employee retention tax credit in 2022; 2021 had $936K PPP loan forgiveness.","L-series devices (LX9/LT7) sales grew 360% vs 2021; expected to continue growth.","SpinDx THC saliva detection testing validates against LCMS at ~10 ng/mL; commercial launch targeted for 2024.","Supply chain disruptions and higher R&D spending drove loss despite revenue recovery to pre-pandemic levels."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-23-000341","json":"https://secwatch.observer/filing/0001079973-23-000341.json","markdown":"https://secwatch.observer/filing/0001079973-23-000341.md","text":"https://secwatch.observer/filing/0001079973-23-000341.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323000341/0001079973-23-000341-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323000341/lclc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T03:07:06.597724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}